HaEmek Medical Center, Israel: Anemia, Sickle Cell trials

The registry lists 13 Anemia, Sickle Cell studies with HaEmek Medical Center, Israel as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 2 1No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Phase - IIa - IIb, Trial to Study the Safety, Tolerability and Efficacy of Memantine as a Long-term Treatment of SCDStatus unknownNCT03247218Phase 2
• Sickle Cell Anemia - A Comparative Study Between Three Ethnical Communities, a Multicenter StudyStatus unknownNCT01905787
• Iron Overload and Growth Velocity in Thalassemia and Sickle Cell AnemiaCompletedNCT00972231
• Blood Transfusions in Thalassemia Patients, Complications and Adverse EffectsCompletedNCT00971880
• The Spleen in Sickle Cell Anemia and Sickle Cell ThalassemiaCompletedNCT00971698
• Clinical and Laboratory Characteristics of Sickle Cell Anemia Patients Admitted With FeverCompletedNCT00736060
• Clinical Diagnosis of Teenagers Admitted to Pediatric DepartmentsCompletedNCT00735540
• Sickle Cell Anemia Screening and Prevention in Northern IsraelCompletedNCT00735488
• Clinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell ThalassemiaCompletedNCT00512564
• Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell ThalassemiaCompletedNCT00512226Not applicable
• Sickle Cell Anemia in an Arab Bedouin Village in the Northern IsraelCompletedNCT00481039
• Long Term Follow up in Sickle Cell Patients Treated by HydroxyureaCompletedNCT00480974
• Invasive Infections in Children With HemoglobinopathiesCompletedNCT00456443